Merz is a global aesthetics and neurotoxin company that offers a range of innovative products and solutions for skin and health. Their portfolio includes treatments for aesthetics, dermatology, neurology, and specialty pharma.
Merz was founded in 1908 in Frankfurt, Germany.
In the 1950s, Merz introduced its first aesthetic product, Merz Spezial Cream.
In the 1970s, the company expanded internationally, establishing subsidiaries in the United States and other countries.
In 1995, Merz introduced its first botulinum toxin product, Botulinum Toxin Type A.
In 2013, Merz acquired Anteis SA, a Swiss aesthetics company specializing in dermal fillers.
Today, Merz operates in over 90 countries and is known for its innovation in the field of aesthetics and neurotoxin therapies.
Allergan is a leading pharmaceutical company that offers a range of aesthetic and medical products, including Botox.
Galderma is a dermatology-focused pharmaceutical company that provides a wide range of aesthetic and medical solutions.
Merck is a global pharmaceutical company that offers various healthcare solutions, including dermatology and aesthetics products.
Xeomin is a botulinum toxin type A product used for the treatment of facial wrinkles and muscle spasticity.
Belotero is a range of dermal fillers designed to smooth and correct wrinkles and facial volume loss.
Ultherapy is a non-invasive treatment that uses ultrasound energy to lift and tighten the skin on the face and neck.
Merz is known for its innovative products and treatments in aesthetics and neurotoxin therapies.
Merz is headquartered in Frankfurt, Germany.
Some popular products of Merz include Xeomin, Belotero, and Ultherapy.
Some of the competitors of Merz include Allergan, Galderma, and Merck.
Xeomin is a botulinum toxin type A product used for the treatment of facial wrinkles and muscle spasticity.
